Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. This year over 25,000 cyclists are set to take part in the ride, with events for everyone from beginners to the elite. Professor Tesfaye has undertaken ground-breaking research to help understanding and treatment of the illness. On Wednesday 2nd March, Dr Debbie Wake delivered a presentation discussing the use of My Diabetes My Way in Scotland. He also serves as Chief Scientist at the Scottish Government Health Department and as a Governor of the Health Foundation, which supports innovation and quality improvement in health care. It received the award for Best improvement programme for pregnancy and maternity at QiC Diabetes 2012. From A to G, the strategy allows healthcare professionals to educate patients about Advice, Blood Pressure, Cholesterol, Diabetes Control, Eye-care, Foot-care and Guardian drug therapies to build an effective care plan for their condition.
This was a follow up from an event that was held 18 months ago where the health board asked those who need the services, what we wanted and how we could help shape the care we are entitled to. The splendour of the Manchester Central Convention Complex was unknown back then (a comparison of the Hillsborough stadium with Old Trafford is probably appropriate) and the meetings were typically held in University facilities. My part at the conference, in the grand scheme of things, is actually quite small, meaning that what I will contribute to the discussion needs to be big – it needs to make an impact and ensure that discussions remain patient focused. It is caring for those and especially the acutely ill person that the education in the session was aimed at. ABCD would like all departments in the UK to establish such meetings. Hopefully we raised the Groups profile with the many medical staff attending. Four abstracts will be selected for oral presentations.
Professor Keen, who sat on the Rank Prize Funds Committee for over 22 years, was a physician and epidemiologist who did much to shape the modern understanding of diabetes and its treatment. ABCD members Stephanie Amiel and Gerry Rayman are involved in the development of recommendations in this area. Bob Ryder was a guest delegate to contribute to the proceedings. Dialogue with the SAC for Endocrinology and Diabetes ABCD will be discussing credentialing in diabetes with Asif Ali, the new Chair of the Speciality Advisory Committee for Endocrinology and Diabetes. If you have any strong views, please discuss these with our Chair. He has represented Diabetes UK at various events promoting the work of the charity. “We understand we have to do that with a restricted-resource health service, that we have to look at what we can stop doing and what we can move to, but I don’t quite understand why you think NICE shouldn’t have put out there what we should be aspiring to,” she told Dr Kar.
Hello and goodbye Barbara Young has stepped down, and Chris Askew is the new CEO of Diabetes UK. In March 2010, Fiona presented the Mary Mackinnon lecture at the Diabetes UK Annual Professional Conference, entitled “The Spirit of Respect”. Steve Olczac has agreed to join the select list of ABCD Ambassadors. Alison Gallagher, Marc Atkin and Karen Adamson have joined the ABCD committee. Jyothis George has moved on for a career opportunity in industry. The birth of IPN-UK ABCD is pleased to announce the formation of a new National Insulin Pump Network, called IPN-UK, hosted by ABCD. Its inaugural conference will be in Manchester on 21st April 2016, immediately before the ABCD spring conference.
Emma Wilmot and team are preparing the programme. Great news for corporate supporters There is a new opportunity for the industry (both pharma and pump/device companies) to support and get involved with the work of ABCD in 2016. Tony Robinson (ABCD Treasurer) has designed corporate membership packages, each of which include entitlements to advertise in, and purchase reprints from, BJDVD. National Audit Office preparing a follow-up report We await publication of this follow-up report on the state of diabetes care in England soon. The NAO has taken evidence from a wide range of stakeholders, including ABCD. Obesity services in England New Tier 3 obesity services are being supported and developed all over the country. More help may be available from Rob Gregory (ABCD) and John Wass (RCP London) if any team has any problems in establishing these models locally.
Degludec-aspart beats premix as first insulin in type 2 diabetes Twice-daily insulin degludec/aspart provided superior FPG control (by 1 mmol/L on average) and a reduced rate of overall and nocturnal hypoglycaemia, compared with biphasic insulin aspart 30 in a 26-week RCT in insulin-naïve adults with type 2 diabetes. A non-inferior reduction in HbA1c was observed. Diabet Med 2015 Oct 4. doi: 10.1111/dme.12982. Structured diabetes education improves outcomes in type 2 diabetes In this study of over 24,000 patients, those who received an education programme benefitted by fewer hospitalization events (22 vs. 25%), fewer emergency department visits (40 vs. 44%) and fewer hospitalizations (17 vs.
200 per 100 patients). Diabet Med 2015 Oct 3. Mr Gibson was always organising events for fundraising, providing information about the support groups, the organisation and assisting in the running of care support events and numerous other activities. Over-diagnosis of depression in type 1 diabetes Diagnosis of depression based on a health questionnaire led to higher false-positive diagnoses compared with a structured clinical review (52 vs. 71%). Many of these cases were related to diabetes- related distress rather than clinical depression. Diabet Med 2015 Oct 3.
doi: 10.1111/dme.12973. Hypoglycaemia and increased mortality in hospital Of 921,306 people with diabetes hospitalised in Spain, 46,408 developed secondary hypoglycaemia; these people were at increased risk for mortality (OR=1.24), early readmission (OR=1.20), and increased length of stay (OR=1.24), compared with those free of hypoglycaemia. Endocr Pract 2014;20:870-5. doi: 10.4158/EP14006.OR.